there is the potential for: Ischemic injury due to potent vasoconstrictor action and tissue hypoxia Mild bradycardia, probably as a reflex result of a rise in blood pressure Arrhythmias Anxiety Transient headache Respiratory difficulty Pharmacokinetics: When released from nerve terminals, its actions are primarily (75%) terminated by neuronal reuptake Diffusion and degredation by extracellualr COMT contribute to a lesser extent
Mental Clarity B vitamins, magnesium, and amino acids support cognitive function, reduce brain fog, and enhance focus and concentration
A single batch with slightly reduced potency from a compounding pharmacy is a minor inconvenience
Levels decline with age, which is why thinning accelerates after thirty
Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 41471311] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context